Weight loss program could open door to kidney transplants for obese patients

NCT ID NCT06396416

Recruiting now Disease control Sponsor: Western University, Canada Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times

Summary

This study tests a virtual weight management program for 60 adults with obesity and advanced kidney disease who want to lose weight to become eligible for a kidney transplant. Participants either join the program (which includes coaching and a weight-loss medication called semaglutide) or continue their usual care. The main goal is to see if this approach is practical for a larger trial.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome Obesity obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASE OBESITY

Contacts and locations

Locations

London Health Sciences Centre
RECRUITING

London, Ontario, N6A 5A5, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.